N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)

C151H116Cl4N30O12S2 — CID 159125035

IUPACN-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)
SMILESO=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccc(Cl)cc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1
InChIInChI=1S/2C26H17Cl2N5O2.C26H25N5O2.C25H23N5O2.2C24H17N5O2S/c27-19-4-1-5-20(28)23(19)26(35)31-18-10-11-21-22(13-18)33-24(32-21)15-6-8-17(9-7-15)30-25(34)16-3-2-12-29-14-16;27-17-5-9-20(21(28)12-17)26(35)31-19-8-10-22-23(13-19)33-24(32-22)15-3-6-18(7-4-15)30-25(34)16-2-1-11-29-14-16;32-25(18-5-2-1-3-6-18)29-21-12-13-22-23(15-21)31-24(30-22)17-8-10-20(11-9-17)28-26(33)19-7-4-14-27-16-19;31-24(17-4-1-2-5-17)28-20-11-12-21-22(14-20)30-23(29-21)16-7-9-19(10-8-16)27-25(32)18-6-3-13-26-15-18;2*30-23(16-2-1-10-25-13-16)26-18-5-3-15(4-6-18)22-28-20-8-7-19(12-21(20)29-22)27-24(31)17-9-11-32-14-17/h2*1-14H,(H,30,34)(H,31,35)(H,32,33);4,7-16,18H,1-3,5-6H2,(H,28,33)(H,29,32)(H,30,31);3,6-15,17H,1-2,4-5H2,(H,27,32)(H,28,31)(H,29,30);2*1-14H,(H,26,30)(H,27,31)(H,28,29)
InChIKeyKGEBFLGFSVMTAT-UHFFFAOYSA-N
MW2748.73 g/mol
LogP33.66
Rot. Bonds30

About N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)

N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) (PubChem CID 159125035) has the molecular formula C151H116Cl4N30O12S2 and a molecular weight of 2748.73 g/mol. Its IUPAC name is N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide).

Molecular Properties

Compound NameN-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)
PubChem CID159125035
Molecular FormulaC151H116Cl4N30O12S2
Molecular Weight2748.73 g/mol
Exact Mass2744.76
IUPAC NameN-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)
SMILESO=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccc(Cl)cc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1
InChIInChI=1S/2C26H17Cl2N5O2.C26H25N5O2.C25H23N5O2.2C24H17N5O2S/c27-19-4-1-5-20(28)23(19)26(35)31-18-10-11-21-22(13-18)33-24(32-21)15-6-8-17(9-7-15)30-25(34)16-3-2-12-29-14-16;27-17-5-9-20(21(28)12-17)26(35)31-19-8-10-22-23(13-19)33-24(32-22)15-3-6-18(7-4-15)30-25(34)16-2-1-11-29-14-16;32-25(18-5-2-1-3-6-18)29-21-12-13-22-23(15-21)31-24(30-22)17-8-10-20(11-9-17)28-26(33)19-7-4-14-27-16-19;31-24(17-4-1-2-5-17)28-20-11-12-21-22(14-20)30-23(29-21)16-7-9-19(10-8-16)27-25(32)18-6-3-13-26-15-18;2*30-23(16-2-1-10-25-13-16)26-18-5-3-15(4-6-18)22-28-20-8-7-19(12-21(20)29-22)27-24(31)17-9-11-32-14-17/h2*1-14H,(H,30,34)(H,31,35)(H,32,33);4,7-16,18H,1-3,5-6H2,(H,28,33)(H,29,32)(H,30,31);3,6-15,17H,1-2,4-5H2,(H,27,32)(H,28,31)(H,29,30);2*1-14H,(H,26,30)(H,27,31)(H,28,29)
InChIKeyKGEBFLGFSVMTAT-UHFFFAOYSA-N
XLogP33.66
TPSA598.62 Ų
H-Bond Donors18
H-Bond Acceptors26
Rotatable Bonds30
Heavy Atoms199
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002748.73
LogP ≤ 533.66
H-Bond Donors ≤ 518
H-Bond Acceptors ≤ 1026

Analyze N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)?
The IUPAC name of N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) (CID 159125035) is N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide).
What is the SMILES notation for N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)?
The canonical SMILES for N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) is O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)C4CCCCC4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4c(Cl)cccc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccc(Cl)cc4Cl)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.O=C(Nc1ccc(-c2nc3ccc(NC(=O)c4ccsc4)cc3[nH]2)cc1)c1cccnc1.
What is the InChIKey of N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)?
The InChIKey is KGEBFLGFSVMTAT-UHFFFAOYSA-N. The full InChI is InChI=1S/2C26H17Cl2N5O2.C26H25N5O2.C25H23N5O2.2C24H17N5O2S/c27-19-4-1-5-20(28)23(19)26(35)31-18-10-11-21-22(13-18)33-24(32-21)15-6-8-17(9-7-15)30-25(34)16-3-2-12-29-14-16;27-17-5-9-20(21(28)12-17)26(35)31-19-8-10-22-23(13-19)33-24(32-22)15-3-6-18(7-4-15)30-25(34)16-2-1-11-29-14-16;32-25(18-5-2-1-3-6-18)29-21-12-13-22-23(15-21)31-24(30-22)17-8-10-20(11-9-17)28-26(33)19-7-4-14-27-16-19;31-24(17-4-1-2-5-17)28-20-11-12-21-22(14-20)30-23(29-21)16-7-9-19(10-8-16)27-25(32)18-6-3-13-26-15-18;2*30-23(16-2-1-10-25-13-16)26-18-5-3-15(4-6-18)22-28-20-8-7-19(12-21(20)29-22)27-24(31)17-9-11-32-14-17/h2*1-14H,(H,30,34)(H,31,35)(H,32,33);4,7-16,18H,1-3,5-6H2,(H,28,33)(H,29,32)(H,30,31);3,6-15,17H,1-2,4-5H2,(H,27,32)(H,28,31)(H,29,30);2*1-14H,(H,26,30)(H,27,31)(H,28,29).
What are the key properties of N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide)?
N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) has a molecular weight of 2748.73 g/mol, XLogP of 33.66, 30 rotatable bonds, 18 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[6-(cyclohexanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-(cyclopentanecarbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,4-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;N-[4-[6-[(2,6-dichlorobenzoyl)amino]-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide;bis(N-[4-[6-(thiophene-3-carbonylamino)-1H-benzimidazol-2-yl]phenyl]pyridine-3-carboxamide) is sourced from PubChem (CID 159125035), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).